Waldencast 2Q22 Investor Results

Footprint Expansion INTERNATIONAL +45.9% GROWTH ● DRIVERS LAUNCH OF OBAGI CLINICAL® ENTRY PRICE POINT RANGE TAILORED NPD SCAR CREAM FOR ASIA PACIFIC LAUNCH OF D2C STRATEGY + AMAZON STRATEGY ● ● SOUTH-EAST ASIA Source: H1 2022 vs. H1 2021 Obagi Internal Sales Data. Euromonitor +81% $9.2BN GROWTH #1 BRIGHTENING MARKET GLOBALLY DARK SPOT DISRUPTOR discoloration correcting serum CLINICALLY PROVEN TO FADE DARK SPOTS AND IMPROVE UNEVEN SKIN TONE FOR AN OVERALL BRIGHTER AND SMOOTHER COMPLEXION OBAGI CLINICAL 1 fl. oz. (30 ml) OBAGI

View entire presentation